Dihydroquercetin is a flavanonol with antimicrobial, antifungal, antibacterial, anti-inflammatory, and antioxidant properties which are beneficial to health. Taxifolin can be found in plant-based foods including plant - based foods, as well as beverages or cherry-wood-aged vinegars
The global Dihydroquercetin market worth US$ 85 million by 2028, growing at a CAGR of 5.6%
Several countries have shut down airfields, ports, and residential & commercial transportation due to the COVID-19 pandemic and lockdowns. This had an impact on worldwide manufacturing activity and operations, as well as the economies of numerous countries. Complete and partial country-wide lockdowns have a significant impact on the manufacturing sector's demand and supply sides. Companies are making concerted and urgent efforts to adapt to constraints, and they must now implement more stringent safety precautions for their workers and people, as well as improve operational efficiencies in a "new normal." Companies continue to employ diverse tactics and try to manage key activities as the issue continues a worldwide scale, and revenues have already been impacted considerably across business areas, as well as throughout all major or developing economies. Experts are still unsure if the situation and issues will clear up or persist indefinitely, but the introduction of new variations and potential outbreak are predicted to loom over the next few seasons.
The Purity <95% segment accounted for the highest market share
Purity of less than 95% Taxifolin is a found naturally polyphenol chemical extracted from the Taxus cuspidata plant. It possesses a wide spectrum of biological actions, including antioxidant, anti-inflammatory, or anticancer properties. Taxifolin with a purity of less than 95% contains impurities like catechin, epigallocatechin, gallic acid, as well as other phenolic acids. Taxifolin of this sort is commonly used during food and beverage industries. Low purity taxifolin is another name for this sort of taxifolin. It can be used to treat a variety of illnesses, including cancer, diabetes, and coronary heart disease.
European region held highest market share
According to regional analysis, Europe held the greatest revenue share in the worldwide taxifolin market by 2022, and so this dominance is likely to continue during the forecast period. This is owing to the increased-on use taxifolin in a variety of end-use applications, including food and cosmetics. The rising prevalence of bone cancer in the region, as well as increased government initiatives to raise awareness about cancer & treatment for cancer, plus R&D projects for research but instead development in the field, are all contributing to the market's growth. In 2022, the North American market accounts for a substantial portion of worldwide revenue. The region's pharmaceutical industry is well-established, and increased taxifolin usage in drugs due to its antimicrobial and antifungal properties is likely to fuel revenue growth inside the taxifolin market in The Region. Due to increased investments by governments and the private sector in the region focused on research & development of medications with low or no side effects, the Apac market is predicted to grow at the fastest rate over the forecast period. Government efforts to improve local industry of inexpensive pharmaceuticals that could still largely cut imports, particularly in China, are likely to fuel revenue particularly in the Asia Asia taxifolin market.
Taxifolin has a crucial role in avoiding oxidative stress and protecting the body from free radicals. It also acts as an anti-cancer chemical during chemotherapy.
According to the current research, the growth of Dihydroquercetin in 2021 would be significantly different than the previous year. According to the most cautious predictions, the global Dihydroquercetin addressable market would increase by percent year on year in 2021, reaching US$ 54 million in 2022. The global market for Dihydroquercetin will grow at a 6.8% CAGR by terms of revenue over the forecast period, reaching US$ 72 million in 2029.
Growing global population and accompanying need for healthy alternatives, technological developments, improved cold chain facilities, plus increased awareness about health and fitness amongst people worldwide are likely to fuel global dihydroquercetin market earnings growth. Furthermore, taxifolin is used to encourage plant development, implying that the continually expanding agriculture sector is a substantial contributor to market growth.
Due to product properties including such antibacterial, anti-inflammatory, antifungal, as well as antioxidant, increasing demand for and acceptance with taxifolin throughout various end use industries including such medical, healthcare, farming, food, and other sectors is likely to increase taxifolin market revenue growth.
Purity is just a technical term that refers to the amount of a specific constituent in a solution. Purity is expressed using the percentage (%) symbol. "Purity >95 percent" in the instance of taxifolin means that taxifolin makes up more than 95 percent of the total concentration of the sample. This leaves less than 5% for other ingredients. Purity of better than 95% Taxifolin is an antioxidant, anti-inflammatory, or anticancer flavonoid. Taxifolin with a purity of greater than 95% contains only trace levels of contaminants. Taxifolin of this sort is commonly utilised in medical and cosmetic purposes. High purity taxifolin is another name for this sort of taxifolin.
Skin cancers are divided into two types: melanoma and non-melanoma. Basal cell carcinoma and squamous cell carcinoma are the most frequent non-melanoma cancers. Skin cancer, often known as melanoma, is the eighth most prevalent malignancy in both women and men. There were approximately 295,000 new cases in 2022. With approximately 1.01 million cases during 2021, semi skin cancer is currently most common malignancy in both men and women, though this figure seems probably low. Aside from that, many cases of cancer go unnoticed or unrecorded: some countries lack cancer databases, some have little or no records, documentation in countries undergoing conflict or other disturbance are likely to be inadequate, as well as some cancer patients refuse to seek medical help.
JW Health Products, Kalenika Group, Kingherbs Ltd., Yunnan Hande Cayman Chemical, Hefei Lifeon Pharma, Adooq Bioscience, and Tianbao Bio-Tech, are some of the firms mentioned in the global dihydroquercetin market.
Dihydroquercetin Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||US$ 72 million.|
|Growth Rate||CAGR of 6.8% during 2021-2028|
|Segment Covered||Type, Application, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and South Africa|
|Key Players Profiled||JW Health Products, Kalenika Group, Kingherbs Ltd., Yunnan Hande Cayman Chemical, Hefei Lifeon Pharma, Adooq Bioscience, and Tianbao Bio-Tech & among others.|
Key Segments of the Dihydroquercetin Market
Type Overview, 2022-2029 (USD Million)
- Purity <95%
Application Overview, 2022-2029 (USD Million)
- Food & Beverages
Regional Overview, 2019 -2029 (USD Million)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
Middle East and South Africa